经巩膜睫状体光凝术治疗新生血管性青光眼的五年随访
Contact transscleral cyclophotocoagulation in the treatment of neovascular glaucoma: a five-year follow-up.
作者信息
Leszczyński Rafał, Domański Robert, Formińska-Kapuścik Maria, Mrukwa-Kominek Ewa, Rokita-Wala Iwona
机构信息
Department of Ophthalmology Medical University of Silesia in Katowice, Katowice, Poland. Rafl
出版信息
Med Sci Monit. 2009 Mar;15(3):BR84-7.
BACKGROUND
The purpose of the study was to evaluate the long-term efficacy of contact transscleral cyclophotocoagulation (TSCPC) performed after panretinal photocoagulation and cryoapplication in patients with angle closure neovascular glaucoma.
MATERIAL/METHODS: Thirty eyes of 30 patients with angle closure neovascular glaucoma were enrolled (15 women and 15 men, mean age: 55+/-21 years). Diode TSCPC was performed in all patients after panretinal photocoagulation and cryotherapy. Follow-up was 60 months.
RESULTS
The mean pretreatment and postoperative intraocular pressures (IOPs) were 39.8+/-12 and 20.6+/-3.6 mmHg, respectively (p<0.00001). The mean number of treatment sessions was 2.4+/-1.5 (range: 1+/-7), with 18 eyes receiving only one treatment. There was a decrease in visual acuity in 3, hyphema in 4, uveitis in 2, cataract in 3, and phthisis in 1 eye.
CONCLUSIONS
- TSCPC provides long-term control of IOP in patients with angle closure neovascular glaucoma. 2. Laser panretinal photocoagulation and cryoapplication should be considered before TSCPC. 3. TSCPC is associated with numerous complications, hyphema being the most frequent.
背景
本研究旨在评估在全视网膜光凝和冷冻治疗后对闭角型新生血管性青光眼患者进行接触式经巩膜睫状体光凝（TSCPC）的长期疗效。
材料/方法：纳入30例闭角型新生血管性青光眼患者的30只眼（15例女性和15例男性，平均年龄：55±21岁）。所有患者在全视网膜光凝和冷冻治疗后均进行了二极管TSCPC。随访60个月。
结果
术前和术后平均眼压（IOP）分别为39.8±12和20.6±3.6 mmHg（p<0.00001）。平均治疗次数为2.4±1.5（范围：1±7），18只眼仅接受了一次治疗。3只眼视力下降，4只眼出现前房积血，2只眼发生葡萄膜炎，3只眼出现白内障，1只眼眼球痨。
结论
- TSCPC可长期控制闭角型新生血管性青光眼患者的眼压。2. 在TSCPC之前应考虑激光全视网膜光凝和冷冻治疗。3. TSCPC与多种并发症相关，前房积血最为常见。
Zotero 插件